Mark SimonFounder

United States - Cambridge, Massachusetts

I enjoy bringing novel solutions to long standing problems.

While at MIT, I was the principle inventor of the Automated Fast Flow Peptide Synthesis platform, accelerating chemical peptide synthesis nearly 100 fold while substantially improving yield and purity. Upon graduation, I moved to Ginkgo Bioworks where I developed a keen interest in biochemical pathway design. With this new interest, I was a key driver of intellectual property developed in partnership with Synlogic, solving decades old problems with therapeutic amino acid degradation pathways. I was also a principle designer of the biosynthetic pathways for the successful response to the DARPA ReVector program, as well as many unannounced projects.

I am currently commercializing my graduate work as CEO of Amide technologies, and providing technical advice on biochemical pathway design for a very cool set of programs at Bluestem Biosciences.

I always enjoy talking science and I have an abiding interested in directed evolution, so if you're designing some cool bugs, interested in polyamide drugs, or curious about Amide's unique design capabilities, please reach out!